Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired_by |
gptkb:Abb_Vie
|
| gptkbp:develops |
therapeutics for neurological disorders
|
| gptkbp:focuses_on |
neuroscience research
|
| gptkbp:founded_by |
gptkb:Allergan,_Inc.
|
| gptkbp:headquarters |
gptkb:Irvine,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Allergan Neuroscience
|
| gptkbp:operates_in |
gptkb:pharmaceuticals
|
| gptkbp:part_of |
gptkb:Allergan
|
| gptkbp:products |
gptkb:Botox
gptkb:Vraylar Namenda |
| gptkbp:research_areas |
gptkb:depression
gptkb:neurodegenerative_diseases chronic pain schizophrenia |
| gptkbp:bfsParent |
gptkb:Allergan
|
| gptkbp:bfsLayer |
5
|